Histamine H3 receptor: A novel therapeutic target in alcohol dependence?

Frontiers in Systems Neuroscience

Volumn , Issue MAY 2012, 2012, Pages

  Nuutinen, Saara ^a   Vanhanen, Jenni ^a   Mäki, Tiia ^a   Panula, Pertti ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Addiction; Alcohol; Conditioned place preference; Drinking in the dark; H3 receptor; Histamine; Reward; Self administration

Indexed keywords

5 (4 CYANOPHENYL) 2 [2 (2 METHYL 1 IMIDAZOLIDINYL)ETHYL]BENZOFURAN; 6 (3 CYCLOBUTYL 2,3,4,5 TETRAHYDRO 1H 3 BENZAZEPIN 7 YLOXY) N METHYLNICOTINAMIDE; ALPHA FLUOROMETHYLHISTIDINE; ALPHA METHYLHISTAMINE; BACLOFEN; BAVISANT; CANNABINOID RECEPTOR; CIPROXIFAN; CLOBENPROPIT; CORTICOTROPIN RELEASING FACTOR; DOPAMINE; GHRELIN; HISTAMINE; HISTAMINE H3 RECEPTOR; HISTAMINE H3 RECEPTOR AGONIST; HISTAMINE H3 RECEPTOR ANTAGONIST; HISTIDINE; IMMEPIP; JNJ 10181457; JNJ 39220675; MEPYRAMINE; NEUROPEPTIDE Y; NORADRENALIN; ONDANSETRON; PITOLISANT; SEROTONIN; TELE METHYLHISTAMINE; THIOPERAMIDE; TOPIRAMATE; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ALCOHOL CONSUMPTION; ALCOHOLISM; ALLERGIC RHINITIS; ARTICLE; ATTENTION DEFICIT DISORDER; BEHAVIOR CONTROL; BRAIN LEVEL; CENTRAL NERVOUS SYSTEM; DAYTIME SOMNOLENCE; DRUG MECHANISM; DRUG TARGETING; ENZYME ACTIVITY; EPILEPSY; HIGH RISK BEHAVIOR; HISTAMINE METABOLISM; HISTAMINERGIC SYSTEM; HUMAN; HYPERALGESIA; NARCOLEPSY; NERVE CELL; NEUROMODULATION; NEUROTRANSMISSION; NONHUMAN; PLACE PREFERENCE; SCHIZOPHRENIA;

EID: 84864986234     PISSN: 16625137     EISSN: None     Source Type: Journal    
DOI: 10.3389/fnsys.2012.00036     Document Type: Article

References (68)

1. Addolorato, G., Caputo, F., Capristo, E., Domenicali, M., Bernardi, M., Janiri, L., Agabio, R., Colombo, G., Gessa, G. L., and Gasbarrini, G. (2002). Baclofen efficacy in reducing alcohol craving and intake: a preliminary double-blind randomized controlled study. Alcohol Alcohol. 37, 504-508.
2. Ahtee, L., and Eriksson, K. (1973). Regional distribution of brain 5hydroxytryptamine in rat strains selected for their alcohol intake. Ann. N. Y. Acad. Sci. 215, 126-134.
3. Ahtee, L., and Eriksson, K. (1975). Dopamine and noradrenaline content in the brain of rat strains selected for their alcohol intake. Acta Physiol. Scand. 93, 563-565.
4. Airaksinen, M. S., Paetau, A., Paljarvi, L., Reinikainen, K., Riekkinen, P., Suomalainen, R., and Panula, P. (1991). Histamine neurons in human hypothalamus: anatomy in normal and Alzheimer diseased brains. Neuroscience 44, 465-481.
5. Alakarppa, K., Tupala, E., Mantere, T., Sarkioja, T., Rasanen, P., Tarhanen, J., Tiihonen, J., and Tuomisto, L. (2002). Effect of alcohol abuse on human brain histamine and tele-methylhistamine. Inflamm. Res. 51(Suppl. 1), S40-S41.
6. Brabant, C., Alleva, L., Grisar, T., Quertemont, E., Lakaye, B., Ohtsu, H., Lin, J. S., Jatlow, P., Picciotto, M. R., and Tirelli, E. (2009). Effects of the H3 receptor inverse agonist thioperamide on cocaineinduced locomotion in mice: role of the histaminergic system and potential pharmacokinetic interactions. Psychopharmacology (Berl.) 202, 673-687.
7. Brabant, C., Alleva, L., Quertemont, E., and Tirelli, E. (2010). Involvement of the brain histaminergic system in addiction and addiction-related behaviors: A comprehensive review with emphasis on the potential therapeutic use of histaminergic compounds in drug dependence. Prog. Neurobiol. 92, 421-441.
8. Brabant, C., Charlier, Y., Quertemont, E., and Tirelli, E. (2005). The H3 antagonist thioperamide reveals conditioned preference for a context associated with an inactive small dose of cocaine in C57BL/6J mice. Behav. Brain Res. 160, 161-168.
9. Brabant, C., Quertemont, E., Anaclet, C., Lin, J. S., Ohtsu, H., and Tirelli, E. (2007). The psychostimulant and rewarding effects of cocaine in histidine decarboxylase knockout mice do not support the hypothesis of an inhibitory function of histamine on reward. Psychopharmacology (Berl.) 190, 251-263.
10. Brioni, J. D., Esbenshade, T. A., Garrison, T. R., Bitner, S. R., and Cowart, M. D. (2011). Discovery of histamine H3 antagonists for the treatment of cognitive disorders and Alzheimer's disease. J. Pharmacol. Exp. Ther. 336, 38-46.
11. Cloninger, C. R., Sigvardsson, S., and Bohman, M. (1988). Childhood personality predicts alcohol abuse in young adults. Alcohol. Clin. Exp. Res. 12, 494-505.
12. Cowart, M., Pratt, J. K., Stewart, A. O., Bennani, Y. L., Esbenshade, T. A., and Hancock, A. A. (2004). A new class of potent non-imidazole H(3) antagonists: 2-aminoethylbenzofurans. Bioorg. Med. Chem. Lett. 14, 689-693.
13. Cunningham, C. L., Ferree, N. K., and Howard, M. A. (2003). Apparatus bias and place conditioning with ethanol in mice. Psychopharmacology (Berl.) 170, 409-422.
14. Cunningham, C. L., Gremel, C. M., and Groblewski, P. A. (2006). Druginduced conditioned place preference and aversion in mice. Nat. Protoc. 1, 1662-1670.
15. Edwards, S., Kenna, G. A., Swift, R. M., and Leggio, L. (2011). Current and promising pharmacotherapies, and novel research target areas in the treatment of alcohol dependence: a review. Curr. Pharm. Des. 17, 1323-1332.
16. Eriksson, K. (1968). Genetic selection for voluntary alcohol consumption in the albino rat. Science 159, 739-741.
17. Esbenshade, T. A., Fox, G. B., Krueger, K. M., Miller, T. R., Kang, C. H., Denny, L. I., Witte, D. G., Yao, B. B., Pan, L., Wetter, J., Marsh, K., Bennani, Y. L., Cowart, M. D., Sullivan, J. P., and Hancock, A. A. (2005). Pharmacological properties of ABT-239 [4-(2-{2-[(2R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: I. Potent and selective histamine H3 receptor antagonist with drug-like properties. J. Pharmacol. Exp. Ther. 313, 165-175.
18. Ferrada, C., Ferre, S., Casado, V., Cortes, A., Justinova, Z., Barnes, C., Canela, E. I., Goldberg, S. R., Leurs, R., Lluis, C., and Franco, R. (2008). Interactions between histamine H3 and dopamine D2 receptors and the implications for striatal function. Neuropharmacology 55, 190-197.
19. Ferrada, C., Moreno, E., Casado, V., Bongers, G., Cortes, A., Mallol, J., Canela, E. I., Leurs, R., Ferré, S., Lluís, C., and Franco, R. (2009). Marked changes in signal transduction upon heteromerization of dopamine D1 and histamine H3 receptors. Br. J. Pharmacol. 157, 64-75.
20. Fogel, W. A., Michelsen, K. A., Granerus, G., Sasiak, K., Andrzejewski, W., Panula, P., and Maslinski, C. (2002). Neuronal storage of histamine in the brain and tele-methylimidazoleacetic acid excretion in portocaval shunted rats. J. Neurochem. 80, 375-382.
21. Fox, G. B., Esbenshade, T. A., Pan, J. B., Radek, R. J., Krueger, K. M., Yao, B. B., Browman, K. E., Buckley, M. J., Ballard, M. E., Komater, V. A., Miner, H., Zhang, M., Faghih, R., Rueter, L. E., Bitner, R. S., Drescher, K. U., Wetter, J., Marsh, K., Lemaire, M., Porsolt, R. D., Bennani, Y. L., Sullivan, J. P., Cowart, M. D., Decker, M. W., and Hancock, A. A. (2005). Pharmacological properties of ABT-239 [4-(2-{2-[(2R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: II. Neurophysiological characterization and broad preclinical efficacy in cognition and schizophrenia of a potent and selective histamine H3 receptor antagonist. J. Pharmacol. Exp. Ther. 313, 176-190.
22. Galici, R., Rezvani, A. H., Aluisio, L., Lord, B., Levin, E. D., Fraser, I., Boggs, J., Welty, N., Shoblock, J. R., Motley, S. T., Letavic, M. A., Carruthers, N. I., Dugovic, C., Lovenberg, T. W., and Bonaventure, P. (2011). JNJ-39220675, a novel selective histamine H(3) receptor antagonist, reduces the abuse-related effects of alcohol in rats. Psychopharmacology (Berl) 214, 829-841.
23. Garbarg, M., Barbin, G., Rodergas, E., and Schwartz, J. C. (1980). Inhibition of histamine synthesis in brain by alpha-fluoromethylhistidine, a new irreversible inhibitor: in vitro and in vivo studies. J. Neurochem. 35, 1045-1052.
24. Giannoni, P., Medhurst, A. D., Passani, M. B., Giovannini, M. G., Ballini, C., Corte, L. D., and Blandina, P. (2010). Regional differential effects of the novel histamine H3 receptor antagonist 6-[(3-cyclobutyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)oxy]-N-methyl-3-p yridinecarboxamide hydrochloride (GSK189254) on histamine release in the central nervous system of freely moving rats. J. Pharmacol. Exp. Ther. 332, 164-172.
25. Giannoni, P., Passani, M. B., Nosi, D., Chazot, P. L., Shenton, F. C., Medhurst, A. D., Munari, L., and Blandina, P. (2009). Heterogeneity of histaminergic neurons in the tuberomammillary nucleus of the rat. Eur. J. Neurosci. 29, 2363-2374.
26. Goldstein, D. B., and Kakihana, R. (1977). Circadian rhythms of ethanol consumption by mice: a simple computer analysis for chronopharmacology. Psychopharmacology (Berl.) 52, 41-45.
27. Gong, Y. X., Zhang, W. P., Shou, W. T., Zhong, K., and Chen, Z. (2010). Morphine induces conditioned place preference behavior in histidine decarboxylase knockout mice. Neurosci. Lett. 468, 115-119.
28. Green, A. S., and Grahame, N. J. (2008). Ethanol drinking in rodents: is freechoice drinking related to the reinforcing effects of ethanol? Alcohol 42, 1-11.
29. Haas, H., and Panula, P. (2003). The role of histamine and the tuberomamillary nucleus in the nervous system. Nat. Rev. Neurosci. 4, 121-130.
30. Ireland-Denny, L., Parihar, A. S., Miller, T. R., Kang, C. H., Krueger, K. M., Esbenshade, T. A., and Hancock, A. A. (2001). Species-related pharmacological heterogeneity of histamine H(3) receptors. Eur. J. Pharmacol. 433, 141-150.
31. Jin, C. Y., and Panula, P. (2005). The laminar histamine receptor system in human prefrontal cortex suggests multiple levels of histaminergic regulation. Neuroscience 132, 137-149.
32. Johnson, B. A., Ait-Daoud, N., Bowden, C. L., DiClemente, C. C., Roache, J. D., Lawson, K., Javors, M. A., and Ma, J. Z. (2003). Oral topiramate for treatment of alcohol dependence: a randomised controlled trial. Lancet 361, 1677-1685.
33. Kalivas, P. W., and Volkow, N. D. (2011). New medications for drug addiction hiding in glutamatergic neuroplasticity. Mol. Psychiatry 16, 974-986.
34. Kitanaka, N., Kitanaka, J., Nishiguchi, M., Kinoshita, H., Ouchi, H., Minami, T., Hishida, S., and Takemura, M. (2004). Decreased histamine-stimulated phosphoinositide hydrolysis in the cerebral cortex of a rat line selectively bred for high alcohol preference. Neurochem. Res. 29, 1431-1436.
35. Kollonitsch, J., Perkins, L. M., Patchett, A. A., Doldouras, G. A., Marburg, S., Duggan, D. E., Maycock, A. L., and Aster, S. D. (1978). Selective inhibitors of biosynthesis of aminergic neurotransmitters. Nature 274, 906-908.
36. Koob, G. F., and Volkow, N. D. (2010). Neurocircuitry of addiction. Neuropsychopharmacology 35, 217-238.
37. Kraus, T., Schanze, A., Groschl, M., Bayerlein, K., Hillemacher, T., Reulbach, U., Kornhuber, J., and Bleich, S. (2005). Ghrelin levels are increased in alcoholism. Alcohol. Clin. Exp. Res. 29, 2154-2157.
38. Kuhne, S., Wijtmans, M., Lim, H. D., Leurs, R., and de Esch, I. J. (2011). Several down, a few to go: histamine H(3) receptor ligands making the final push towards the market? Expert Opin. Investig. Drugs 20, 1629-1648.
39. Lasseter, H. C., Xie, X., Ramirez, D. R., and Fuchs, R. A. (2010). Prefrontal cortical regulation of drug seeking in animal models of drug relapse. Curr. Top. Behav. Neurosci. 3, 101-117.
40. Ligneau, X., Perrin, D., Landais, L., Camelin, J. C., Calmels, T. P., Berrebi-Bertrand, I., Lecomte, J. M., Parmentier, R., Anaclet, C., Lin, J. S., Bertaina-Anglade, V., la Rochelle, C. D., d'Aniello, F., Rouleau, A., Gbahou, F., Arrang, J. M., Ganellin, C. R., Stark, H., Schunack, W., and Schwartz, J. C. (2007). BF2.649 [1-{3-[3-(4-Chloro phenyl)propoxy]propyl}piperidine, hydrochloride], a nonimidazole inverse agonist/antagonist at the human histamine H3 receptor: Preclinical pharmacology. J. Pharmacol. Exp. Ther. 320, 365-375.
41. Lintunen, M., Hyytia, P., Sallmen, T., Karlstedt, K., Tuomisto, L., Leurs, R., Kiianmaa, K., Korpi, E. R., and Panula, P. (2001). Increased brain histamine in an alcohol-preferring rat line and modulation of ethanol consumption by H(3) receptor mechanisms. FASEB J. 15, 1074-1076.
42. Lintunen, M., Raatesalmi, K., Sallmen, T., Anichtchik, O., Karlstedt, K., Kaslin, J., Kiianmaa, K., Korpi, E. R., and Panula, P. (2002). Low brain histamine content affects ethanolinduced motor impairment. Neurobiol. Dis. 9, 94-105.
43. Lowery, E. G., and Thiele, T. E. (2010). Pre-clinical evidence that corticotropin-releasing factor (CRF) receptor antagonists are promising targets for pharmacological treatment of alcoholism. CNS Neurol. Disord. Drug Targets 9, 77-86.
44. Lozeva, V., Tuomisto, L., Tarhanen, J., and Butterworth, R. F. (2003). Increased concentrations of histamine and its metabolite, tele-methylhistamine and downregulation of histamine H3 receptor sites in autopsied brain tissue from cirrhotic patients who died in hepatic coma. J. Hepatol. 39, 522-527.
45. Maccioni, P., Colombo, G., and Carai, M. A. (2010). Blockade of the cannabinoid CB1 receptor and alcohol dependence: preclinical evidence and preliminary clinical data. CNS Neurol. Disord. Drug Targets 9, 55-59.
46. McCormick, D. A., and Williamson, A. (1989). Convergence and divergence of neurotransmitter action in human cerebral cortex. Proc. Natl. Acad. Sci. U.S.A. 86, 8098-8102.
47. Medhurst, A. D., Atkins, A. R., Beresford, I. J., Brackenborough, K., Briggs, M. A., Calver, A. R., Cilia, J., Cluderay, J. E., Crook, B., Davis, J. B., Davis, R. K., Davis, R. P., Dawson, L. A., Foley, A. G., Gartlon, J., Gonzalez, M. I., Heslop, T., Hirst, W. D., Jennings, C., Jones, D. N., Lacroix, L. P., Martyn, A., Ociepka, S., Ray, A., Regan, C. M., Roberts, J. C., Schogger, J., Southam, E., Stean, T. O., Trail, B. K., Upton, N., Wadsworth, G., Wald, J. A., White, T., Witherington, J., Woolley, M. L., Worby, A., and Wilson, D. M. (2007). GSK189254, a novel H3 receptor antagonist that binds to histamine H3 receptors in Alzheimer's disease brain and improves cognitive performance in preclinical models. J. Pharmacol. Exp. Ther. 321, 1032-1045.
48. Moreno, E., Hoffmann, H., GonzalezSepulveda, M., Navarro, G., Casado, V., Cortes, A., Mallol, J., Vignes, M., McCormick, P. J., Canela, E. I., Lluís, C., Moratalla, R., Ferré, S., Ortiz, J, and Franco, R. (2011). Dopamine D1-histamine H3 receptor heteromers provide a selective link to the map-kinase signalling in gabaergic neurons of the direct striatal pathway. J. Biol. Chem. 286, 5846-5854.
49. Munzar, P., Nosal, R., and Goldberg, S. R. (1998). Potentiation of the discriminative-stimulus effects of methamphetamine by the histamine H3 receptor antagonist thioperamide in rats. Eur. J. Pharmacol. 363, 93-101.
50. Munzar, P., Tanda, G., Justinova, Z., and Goldberg, S. R. (2004). Histamine H3 receptor antagonists potentiate methamphetamine self-administration and methamphetamine-induced accumbal dopamine release. Neuropsychopharmacology 29, 705-717.
51. Nuutinen, S., Karlstedt, K., Aitta-Aho, T., Korpi, E. R., and Panula, P. (2010). Histamine and H3 receptor-dependent mechanisms regulate ethanol stimulation and conditioned place preference in mice. Psychopharmacology (Berl.) 208, 75-86.
52. Nuutinen, S., Lintunen, M., Vanhanen, J., Ojala, T., Rozov, S., and Panula, P. (2011a). Evidence for the role of histamine H3 receptor in alcohol consumption and alcohol reward in mice. Neuropsychopharmacology 36, 2030-2040.
53. Nuutinen, S., Vanhanen, J., Pigni, M. C., and Panula, P. (2011b). Effects of histamine H3 receptor ligands on the rewarding, stimulant and motor-impairing effects of ethanol in DBA/2J mice. Neuropharmacology 60, 1193-1199.
54. Oishi, R., Shishido, S., Yamori, M., and Saeki, K. (1994). Comparison of the effects of eleven histamine H1-receptor antagonists on monoamine turnover in the mouse brain. Naunyn Schmiedebergs Arch. Pharmacol. 349, 140-144.
55. Okuda, T., Zhang, D., Shao, H., Okamura, N., Takino, N., Iwamura, T., Sakurai, E., Yoshikawa, T., and Yanai, K. (2009). Methamphetamineand 3,4-methylenedioxymethamphetamineinduced behavioral changes in histamine H3-receptor knockout mice. J. Pharmacol. Sci. 111, 167-174.
56. Panula, P., Pirvola, U., Auvinen, S., and Airaksinen, M. S. (1989). Histamine-immunoreactive nerve fibers in the rat brain. Neuroscience 28, 585-610.
57. Pohorecky, L. A. (1991). Stress and alcohol interaction: an update of human research. Alcohol. Clin. Exp. Res. 15, 438-459.
58. Rhodes, J. S., Best, K., Belknap, J. K., Finn, D. A., and Crabbe, J. C. (2005). Evaluation of a simple model of ethanol drinking to intoxication in C57BL/6J mice. Physiol. Behav. 84, 53-63.
59. Rusi, M., Eriksson, K., and Maki, J. (1977). Genetic differences in the susceptibility to acute ethanol intoxication in selected rat strains. Adv. Exp. Med. Biol. 85A, 97-109.
60. Schlicker, E., Malinowska, B., Kathmann, M., and Gothert, M. (1994). Modulation of neurotransmitter release via histamine H3 heteroreceptors. Fundam. Clin. Pharmacol. 8, 128-137.
61. Schnell, D., Strasser, A., and Seifert, R. (2010). Comparison of the pharmacological properties of human and rat histamine H3-receptors. Biochem. Pharmacol. 80, 1437-1449.
62. Sellers, E. M., Toneatto, T., Romach, M. K., Somer, G. R., Sobell, L. C., and Sobell, M. B. (1994). Clinical efficacy of the 5-HT3 antagonist ondansetron in alcohol abuse and dependence. Alcohol. Clin. Exp. Res. 18, 879-885.
63. Shishido, S., Oishi, R., and Saeki, K. (1991). In vivo effects of some histamine H1-receptor antagonists on monoamine metabolism in the mouse brain. Naunyn Schmiedebergs Arch. Pharmacol. 343, 185-189.
64. Suzuki, T., Takamori, K., Misawa, M., and Onodera, K. (1995). Effects of the histaminergic system on the morphine-induced conditioned place preference in mice. Brain Res. 675, 195-202.
65. Takino, N., Sakurai, E., Kuramasu, A., Okamura, N., and Yanai, K. (2009). Roles of the histaminergic neurotransmission on methamphetamine-induced locomotor sensitization and reward: a study of receptors gene knockout mice. Int. Rev. Neurobiol. 85, 109-116.
66. Thorsell, A., Karlsson, R. M., and Heilig, M. (2006). NPY in alcoholism and psychiatric disorders. EXS, 95, 183-192.
67. Tzschentke, T. M. (2007). Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade. Addict. Biol. 12, 227-462.
68. Verdiere, M., Rose, C., and Schwartz, J. C. (1975). Synthesis and release of histamine studied on slices from rat hypothalamus. Eur. J. Pharmacol. 34, 157-168.